Javascript must be enabled to continue!
Mistnatch repair and cancer
View through CrossRef
Abstract
DNA mismatch repair is one of the three known DNA excision repair pathways. Unlike nucleotide and base excision repair, in which the substrate is damaged or altered DNA, mismatch repair acts on undamaged DNA bases which are in in appropriate contexts. Mismatch repair corrects unmodified DNA bases in non Watson-Crick pairings or small distortions generated by the incorrect alignment of two otherwise normal DNA strands. Structural abnormalities such as these are generated during recombination between DNA molecules that are not perfectly homologous, and the phrase ‘mismatch repair’ was originally invoked to explain apparently anomalous recombination frequencies. DNA replication errors are also a major source of mismatches. Mismatch repair acts after replication to rectify mismatches that have evaded proofreading by the replication apparatus. Organisms with defective mismatch repair invariably display increased spontaneous mutation rates. Although some of the later steps of the three excision repair pathways share common components, the initial steps, in which the substrate for repair is identified and marked for correction, can be considered unique for each pathway. There is an additional constraint on substrate recognition during mismatch repair. To achieve biologically significant correction, the repair proteins must not only recognize the structurally anomalous mismatches, but must also obtain information as to which of the mispaired DNA strands is incorrect.
Title: Mistnatch repair and cancer
Description:
Abstract
DNA mismatch repair is one of the three known DNA excision repair pathways.
Unlike nucleotide and base excision repair, in which the substrate is damaged or altered DNA, mismatch repair acts on undamaged DNA bases which are in in appropriate contexts.
Mismatch repair corrects unmodified DNA bases in non Watson-Crick pairings or small distortions generated by the incorrect alignment of two otherwise normal DNA strands.
Structural abnormalities such as these are generated during recombination between DNA molecules that are not perfectly homologous, and the phrase ‘mismatch repair’ was originally invoked to explain apparently anomalous recombination frequencies.
DNA replication errors are also a major source of mismatches.
Mismatch repair acts after replication to rectify mismatches that have evaded proofreading by the replication apparatus.
Organisms with defective mismatch repair invariably display increased spontaneous mutation rates.
Although some of the later steps of the three excision repair pathways share common components, the initial steps, in which the substrate for repair is identified and marked for correction, can be considered unique for each pathway.
There is an additional constraint on substrate recognition during mismatch repair.
To achieve biologically significant correction, the repair proteins must not only recognize the structurally anomalous mismatches, but must also obtain information as to which of the mispaired DNA strands is incorrect.
Related Results
Abstract A21: Enhancing chemotherapeutic responses in CNS malignancy through suppression of hyperactive DNA damage repair pathways
Abstract A21: Enhancing chemotherapeutic responses in CNS malignancy through suppression of hyperactive DNA damage repair pathways
Abstract
Introduction: We are targeting DNA repair pathways to enhance existing chemoradiotherapeutic strategies against medulloblastoma (MB) and malignant glioma (M...
Abstract 3493: Comprehensive analysis of the DNA repair enzyme signature in tumor and blood cells from head and neck cancer patients and correlation with clinical data from a 18-months follow-up study
Abstract 3493: Comprehensive analysis of the DNA repair enzyme signature in tumor and blood cells from head and neck cancer patients and correlation with clinical data from a 18-months follow-up study
Abstract
Head and neck squamous cell carcinoma (HNSCC) is the sixth leading cancer worldwide. It is often associated with a history of smoking/alcohol consumption or...
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Diagnostic Rate of the Cancer by BDORT Utilizing the Cancer Slide
Purpose:
To make a diagnosis of cancer with BDORT (resonance test), we can choose two methods. One is to use a chemical agent like Integrin α5β1 or Oncogene C-f...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
A Conversation Analysis of Repair Trouble Sources, Inadequacy and Positions in the Iraqi University Viva Discussions in English
A Conversation Analysis of Repair Trouble Sources, Inadequacy and Positions in the Iraqi University Viva Discussions in English
Oral interaction is sometimes not articulated by its participants as perfect as they project. The unsuccessful instances of talk in exchange may cause serious communicative breakdo...
Groin hernia surgery in women : outputs, factors, methods and cost-effectiveness
Groin hernia surgery in women : outputs, factors, methods and cost-effectiveness
<p dir="ltr">There is inequity in access to surgical treatment and quality of care globally and this is more pronounced in low-and middle-income countries (LMICs) especially ...
Groin hernia surgery in women : outputs, factors, methods and cost-effectiveness
Groin hernia surgery in women : outputs, factors, methods and cost-effectiveness
<p dir="ltr">There is inequity in access to surgical treatment and quality of care globally and this is more pronounced in low-and middle-income countries (LMICs) especially ...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...

